Acute lupus myocarditis: Clinical features and outcome
Related Experiment Video
Updated: Jun 2, 2026

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction
Published on: October 14, 2016
S Appenzeller1, C A Pineau, A E Clarke
1Divisions of Clinical Immunology/Allergy and Clinical Epidemiology, McGill University Health Centre, Canada.
Insights
Systemic lupus erythematosus (SLE) can cause life-threatening myocarditis, leading to heart failure. Prompt treatment with immunosuppressants and cardiac support improves outcomes in most patients.
Area of Science:
- Cardiology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) can manifest with cardiomyopathy, often due to myocarditis or hypertension.
- Left ventricular dysfunction is a critical and potentially fatal presentation of SLE-related cardiomyopathy.
Observation:
- This study reports three cases of left ventricular failure suggestive of myocarditis in SLE patients.
- Patients presented with acute onset of significantly reduced left ventricular ejection fraction (LVEF).
Findings:
- Treatment involved cardiac support, prednisone, and other immunosuppressive agents.
- Two out of three patients showed improvement in symptoms and LVEF.
Implications:
- Myocarditis is a rare but serious SLE complication requiring prompt diagnosis and management.
- Aggressive immunosuppressive therapy and cardiac support can lead to favorable long-term outcomes for SLE patients with myocarditis.
Background:
Cardiomyopathy in systemic lupus erythematosus (SLE) may be secondary to myocardial inflammation (i.e. myocarditis) or to systemic complications such as hypertension. Symptomatic left ventricular dysfunction is the most common clinical presentation of cardiomyopathy and is potentially life threatening. Identifying the cause is critical as it dictates therapy.
Methods:
We present three cases of left ventricular failure suggestive of myocarditis in SLE patients followed in the Lupus Clinic of the Montreal General Hospital over a 5-year period.
Results:
The most frequent presentation is acute onset of a marked reduction of the left ventricular ejection fraction (LVEF). All patients were treated with cardiac support, prednisone, and additional immunosuppressive medications. Improvement of symptoms and LVEF was observed in two of three patients.
Conclusion:
Myocarditis is a rare, but life-threatening, manifestation of SLE. With immunosuppressive medications and cardiovascular support, the long-term outcome is usually favorable.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management
Pericarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis III: Medical Management
Myocarditis I: Introduction
